State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.

The success of weight loss drugs like Ozempic heavily relies on the effect that they have in your brain, too, according to ...

A recent study from the University of Nottingham suggests that certain diabetes medications might help people drink less ...

What’s unique about GLP-1s—a.k.a. Ozempic, Monjauro, Wegovy, and Zepbound, among others—is that they target hormones, which ...

Lentils are full of fiber, which “slows down digestion,” once again reproducing the effect of the GLP-1 drugs, at a cost of ...